Advancements in Transdermal Drug Delivery
Advancements in Transdermal Drug Delivery is a research topic within Pharmaceutical Science. Science Explorer counts 25k research works in it since 1950. 9.9% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on innovations in transdermal drug delivery systems, including the use of solid lipid nanoparticles, microneedles, skin penetration enhancers, nanostructured lipid carriers, and microemulsion-based drug delivery. It explores advancements in overcoming the skin's barrier function and enhancing skin permeation for effective drug delivery.
- Solid Lipid Nanoparticles
- Microneedles
- Skin Penetration Enhancers
- Nanostructured Lipid Carriers
- Transdermal Drug Delivery
- Skin Barrier Function
- Microemulsion-based Drug Delivery
- Iontophoretic Drug Delivery
- Skin Permeation Enhancement
- Stratum Corneum
- Research works
- 25k fractional, since 1950
- In the world top 10%
- 2.4k per year above
- Top-10% rate
- 9.9% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +37% the tick is no change
- Largest producer
India
32% of the 10 largest, 2022-now
Which countries lead Advancements in Transdermal Drug Delivery research?
By volume, India and China publish the most (1.5k and 1.2k works in 2022-now).
By volume, 2022-now
- 1
India 1.5k works
- 2
China 1.2k works
- 3
United States 651 works
- 4
South Korea 233 works
- 5
Iran 221 works
- 6
United Kingdom 212 works
- 7
Japan 197 works
- 8
Egypt 196 works
- 9
Brazil 178 works
- 10
Indonesia 163 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Advancements in Transdermal Drug Delivery research?
By volume in 2022-now, Hindu College of Pharmacy publishes the most Advancements in Transdermal Drug Delivery research, followed by Chinese Academy of Sciences and Shenyang Pharmaceutical University.
By volume, 2022-now
- 1
Hindu College of Pharmacy
India 60 works
- 2
Chinese Academy of Sciences
China 34 works
- 3
Shenyang Pharmaceutical University
China 33 works
- 4
Centre National de la Recherche Scientifique
France 32 works
- 5
King Saud University
Saudi Arabia 31 works
- 6
Queen's University Belfast
United Kingdom 31 works
- 7
Narsee Monjee Institute of Management Studies
India 30 works
- 8
Sichuan University
China 30 works
- 9
Cairo University
Egypt 29 works
- 10
Islamic Azad University, Tehran
Iran 27 works
Who are the leading researchers in Advancements in Transdermal Drug Delivery?
The most-cited researchers publishing on Advancements in Transdermal Drug Delivery include Zhong Lin Wang, Róbert Langer and Wei Huang.
- 1
Zhong Lin Wang
United States 491k citations
- 2
Róbert Langer
United States 303k citations
- 3
Wei Huang
China 267k citations
- 4
Amirhossein Sahebkar
Iran 258k citations
- 5
Peter John Barnes
United Kingdom 225k citations
- 6
Lei Jiang
China 214k citations
- 7
Hua Zhang
Singapore 196k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Advancements in Transdermal Drug Delivery research done?
The largest centres of Advancements in Transdermal Drug Delivery research in 2022-now are Beijing (China), Seoul (South Korea), Shanghai (China) and Mumbai (India). Among places with at least 20 works in it, it is an unusually large share of all research in Sonīpat.
Largest cities, 2022-now
Where it is the local speciality
- SonīpatIN · 63.0 works21×
Location quotient: how much more of its research is in Advancements in Transdermal Drug Delivery than the world average.
Where is the best place to study Advancements in Transdermal Drug Delivery?
Among universities, judged by research, Queen's University Belfast, Sun Yat-sen University and Zhejiang University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Advancements in Transdermal Drug Delivery, country by countryIs Advancements in Transdermal Drug Delivery research growing?
Output in 2022-2025 was 37% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Advancements in Transdermal Drug Delivery.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Advancements in Transdermal Drug Delivery as a percentage of every work published that year, 0.025% in 2024.
Fractional works of Advancements in Transdermal Drug Delivery over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Advancements in Transdermal Drug Delivery. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.